1.19. Analysis.
Comparison 1 BUD v Placebo: parallel studies, not on oral steroids: 400 mcg/d or less, Outcome 19 Change in daytime use of short‐acting beta2 agonists compared to baseline (puffs/daytime).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.